Related Experiment Video
Updated: May 16, 2026

Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding
Published on: September 21, 2011
[Mechanism of p38 mitogen-activated protein kinase inhibitor SB203580 to glucocorticoid sensitivity]
Wen Li1, Jiang-tao Lin, Li-chao Sun
1Chinese Academy of Medical Sciences, Beijing, China.
Objective:
To establish a model of cigarette smoke exposure to asthmatic rats and glucocorticoid resistance induced by nicotine in alveolar epithelioid cells A549 and study the mechanism for the change of glucocorticoid sensitivity induced by p38 mitogen-activated protein kinase (p38 MAPK) inhibitor SB203580.
Methods:
Sixty Wistar rats were randomly divided into 4 groups: normal group, asthmatic group, cigarette smoke exposure to asthmatic group and SB203580 group. The mRNA expressions of glucocorticoid receptor (GR), heat shock protein 90 (HSP90) and p38 MAPK were detected by real time-polymerase chain reaction (RT-PCR) while their protein expressions detected by Western blot in vivo. A549 cells were divided averagely into 4 groups: group A: normal; group B: 1 µmol/L dexamethasone (DEX); group C: 1 µmol/L DEX +1 µmol/L nicotine; group D: 1 µmol/L DEX +1 µmol/L nicotine+1 µmol/L SB203580. Immunofluorescence staining was used to study the in vitro colocalization of glucocorticoid receptor (GR) in A549 cells.
Results:
The mRNA expression of GR was 0.671 ± 0.002 in cigarette smoke exposure to asthmatic group and 0.595 ± 0.061 in SB203580 group (P = 0.065). The protein expression of GR was 0.700 ± 0.033 in cigarette smoke exposure to asthmatic group and 0.628 ± 0.091 in SB203580 group (P = 0.148). The mRNA expression of HSP90 was 0.558 ± 0.009 in cigarette smoke exposure to asthmatic group and 0.377 ± 0.046 in SB203580 group (P = 0.000). The protein expression of HSP90 was 0.507 ± 0.030 in cigarette smoke exposure to asthmatic group and 0.402 ± 0.050 in SB203580 group (P = 0.005). The mRNA expression of p38 MAPK was 0.971 ± 0.012 in cigarette smoke exposure to asthmatic group and 0.278 ± 0.049 in SB203580 group (P = 0.000). The protein expression of p38 MAPK was 0.982 ± 0.038 in cigarette smoke exposure to asthmatic group and 0.338 ± 0.042 in SB203580 group (P = 0.000). The ratio of GR amount within A549 nucleus versus that in cytoplasm was 0.077 ± 0.047 in group C and 0.592 ± 0.249 in group D (P = 0.000).
Conclusion:
The mechanism of SB203580 enhancing the corticosteroid sensitivity may be improving nuclear translocation of GR to elevate corticosteroid sensitivity.
Insights
This study demonstrates that SB203580 enhances corticosteroid sensitivity in asthma models by improving glucocorticoid receptor (GR) nuclear translocation. This finding offers a potential therapeutic mechanism for glucocorticoid resistance in asthma.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Pharmacology
Background:
- Asthma is a chronic respiratory disease often associated with inflammation and airway hyperresponsiveness.
- Glucocorticoid resistance is a significant clinical challenge in managing severe asthma.
- Cigarette smoke exposure can exacerbate asthma symptoms and contribute to glucocorticoid resistance.
Purpose of the Study:
- To develop a rat model of asthma induced by cigarette smoke exposure.
- To investigate nicotine-induced glucocorticoid resistance in A549 alveolar epithelial cells.
- To elucidate the mechanism by which the p38 MAPK inhibitor SB203580 affects glucocorticoid sensitivity.
Main Methods:
- Establishment of a rat model involving asthma and cigarette smoke exposure.
- In vivo analysis of glucocorticoid receptor (GR), HSP90, and p38 MAPK mRNA and protein expression using RT-PCR and Western blot.
- In vitro study using A549 cells treated with dexamethasone, nicotine, and SB203580.
- Immunofluorescence staining to assess GR nuclear translocation in A549 cells.
Main Results:
- Cigarette smoke exposure significantly altered the expression of GR, HSP90, and p38 MAPK in asthmatic rats.
- Nicotine treatment in A549 cells induced glucocorticoid resistance.
- SB203580 treatment significantly increased the nuclear translocation of GR in A549 cells compared to nicotine-treated cells.
- SB203580 treatment reversed nicotine-induced changes in HSP90 and p38 MAPK expression.
Conclusions:
- The p38 MAPK pathway plays a crucial role in mediating glucocorticoid resistance in asthma.
- SB203580 enhances corticosteroid sensitivity by promoting the nuclear translocation of the glucocorticoid receptor (GR).
- Targeting the p38 MAPK pathway may represent a novel therapeutic strategy for overcoming glucocorticoid resistance in asthma.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
GPCR Desensitization
TGF - β Signaling Pathway
Cushing Syndrome I: Introduction

